The Access Question.
At what point did selling orthopedic products stop being about clinical value and patient outcomes—transforming entirely into a game of […]
Tiger’s Ortho Wisdom 24/7
Sharing with the Orthopedics world my newly created AI clone trained on thousands of orthopedic articles and conversations. Whether you
Pitch Smarter – Test your pitch on BoneChat and get authentic feedback !
The Problem – Vague Silence. Orthopedic startups struggle to secure funding, facing a wall of silence from VCs. Pitch after
Is your content frozen by fear… or fueled by action ?
A Tale of Frozen Ambition Jim, a marketing lead at an orthopedic startup, called me. He had a vision: a
Want to doom your startup?
Simple. Bring on board people and consultants from large established companies—places with flawless organization, top-notch systems, and airtight processes. Done….
How to Run a Cost-Effective Clinical Trial at your Early-Stage Orthopedic Company
Learn the 4 keys to running cost-effective trials with lean data, scalable designs, smart tech, and expert partnerships. Early-stage orthopedic
Top 3 Priorities for an Ortho Startup in the Early Years
Launching an ortho startup? Focus on three essentials in Year Zero: team, product, and customers. Here’s the breakdown. 1. Obsess
A look at Trump’s Tariffs on the Orthopedic industry (as of today).
Key Points Research suggests Trump’s tariffs are likely impacting US-based orthopedic medical device companies, increasing costs and disrupting supply chains.
GLP-1’s improve cervical fusion rates.
But wait there’s more. GLP-1s continue to bring miracles. The new study, “Fusion Outcomes of GLP-1 Agonist Therapy in Multilevel
Game theory is driving more and more Robots.
The Orthopedic cartel like Stryker, Zimmer Biomet, and Johnson & Johnson are players in a high-stakes Game Theory showdown. Stryker’s
GLP-1’s affects on potential orthopedic patients.
GLP-1 drugs (e.g., Ozempic, Mounjaro), primarily used for type 2 diabetes and weight loss, can have several implications for potential
We are guilty of being US-centric. We don’t alway think of disruptive OUS orthos.
Sharing a quick example from S. Korea that has a small US office in Irvine. CG MedTech is a South
5 slowing Ortho trends in 2025
Our industry is shifting fast, and some old ways are losing ground. I am tracking a few changes to keep
Transparency into outside recruiting services
Recruiting is hard work. Companies often exhaust internal efforts before turning to outside recruiters, but what do these pros actually
Who are your real connections ?
Think about the last time you scanned your contacts—LinkedIn, your phone, your mental “network.” How many are real? Not just
7 phases of sales leadership as an Orthopedic company grows.
As a retained recruiter I get to work with orthopedic companies as they grow and mature. The sales needs of
“What’s your biggest challenge right now?
Let me know and I’ll give you a specific suggestion help you with it. Click to ask Tiger Clone and
Like it or not… your company has a reputation around its hiring process.
This message is addressed to company leaders. You may not realize that your company has an industry-wide reputation, not based
2025 UPDATE – The GLP-1 revolution will shrink orthopedic surgeries.
As predicted, the GLP-1 revolution has only accelerated, and this miracle drug will reshape the orthopedic landscape going forward. Recent
Funny time! The 10 best FDA 483 excuses.
Sharing Troy Fugate’s LinkedIN posting.. FDA 483 observations require serious, well-documented corrective actions, but some companies have responded with unbelievable
The 3 overlooked landmines – codes, reps, and VACs.
Early-stage ortho companies obsess over what’s in their grasp—patents, funding, slick prototypes, quality systems, and the FDA/EU regulatory circus. This
The “Rep Light” Business Model for Ortho startups.
For many emerging orthopedic device startups, the conventional path involves building a business around a sales representative-driven model. This typically
Here we go! Hinge Health to test the IPO waters in 2025.
The ONLY orthopedic-related company to pursue the public markets since Monogram (2023) and Treace (2021) is HingeHealth – https://www.hingehealth.com/ On March
24 ortho startups at LSI this week.
The LSI conference has emerged as a premier platform fostering collaboration between orthopedic startups and investors. Its success, in my
Zydus’ $280M Power Move: Acquires 86% Stake in French Hip/Knee co, Amplitude Surgical
The acquisition of Amplitude Surgical by Zydus Lifesciences is highly significant for the hip and knee orthopedic industry for several
New technologies –> new costs.
I have been writing about how simplicity is the answer, choice is a tax on everyone, and some orthopedic device
UPDATE from MedTechDive – Orthofix’s Darkest Day: 3 Executives Fired for Offensive Conduct.
Orthofix’s fired execs’ lewd, ‘graphic’ texts surface in legal battle (MedTechDive) Orthofix didn’t originally specify the reasons behind the 2023
Crutches Be Damned: Why Walking on Broken Bones Is the New Healing Hack
Broken Legs and Ankles Heal Better If You Walk on Them within Weeks (Scientific American) Using crutches for months is
AI Hype vs. AI Reality at AAOS: What You Need to Know.
Not all “AI” in orthopedics is what it seems. As you wander the halls of AAOS, “AI” buzzwords will be
Choice is a tax that we are all paying.
We are the guilty ones. The orthopedic device industry has collectively conditioned our customers to expect unrestricted access to any
Sports Medicine’s big moment is here.
I am noticing a new trend. The sports medicine space is bubbling up with alot of potential this year, and
Spotting Fake Orthopedic Founders
When evaluating early stage orthopedic companies —there’s a hidden challenge: not every founder pitching is the real deal. Marc Andreessen,
The Imminent Demise of “Orthopaedics”
Like it or not, AI will erase the British spellings in Orthopedics forever. The British spelling “orthopaedics,” with its elegant
The Innovation Dilemma: Why Big Ortho must resist internal innovation
In the orthopedic industry’s push for innovation and differentiation, a prevailing storyline suggests that Big Ortho companies stumble due to
A new funding avenue for early stage orthopedic concepts.
If you don’t know OREF, you are living in a cave. OREF was founded in 1955 by orthopedic surgeons to
A Front-Row Seat into 1,000 Orthopedic Startups.
Imagine if someone had visibility into ALL early orthopedic innovation. Even more specifically, if someone had early discussions with startups
Transparency: The Missing Link in Orthopedic Healthcare
Complexity isn’t just a byproduct; it’s often a strategy. The orthopedic device industry, much like credit card companies or car
Fake Nano and Real Nano in Orthopedics
In orthopedics, the term “nano” has become a buzzword, promising revolutionary changes at the smallest scales of material science. However,
Straight Talk: Do Orthopedic Companies Really Value Clinical Data?
I recently shared a blunt thought on LinkedIn: “I’ve come to the conclusion that everyone in orthopedics ‘says’ they want
Medtronic Spine buys Nanovis’ nano technology
Website – https://nanovistechnology.com/ Medtronic buys Nanovis’ nano technology for use in spine implants (MedTechDive) Medtronic will use the technology to
Is This the Dawn of Financial Tightening in US Orthopedic Healthcare?
Recent developments at Mass General Brigham (MGB), where the health system announced the largest layoffs in its history, suggest a
PSA – Startups BEWARE of Predatory Activity from Capital Allocators.
Times are getting strange. I have seen a disturbing trend where some capital allocators engage in predatory practices, particularly targeting
From Bunions to Beyond: The Tale of Minimally Invasive Magic in Foot and Ankle Care.
In the vast, ever-evolving world of orthopedics, there’s a term that whispers through the halls of hospitals and clinics like
Globus acquires Nevro for their spinal cord stimulation for $250M
In simple terms, Nevro Corp. focuses on developing and providing medical devices that help manage chronic pain. They are known
Making sense of the ZB acquisition of P28
This one was hard to gather my thoughts on. It’s kinda boring when a public company buys another public company
The Isolated World of the Orthopedic CEO
In orthopedics, the role of CEO is not just about steering a company through the complexities of healthcare innovation and
REVERSAL – The FDA will be mandating DEI for ortho clinical studies.
UPDATE – After Trump Executive Orders, FDA Removes Diversity Guidance From Website Days after President Trump issued an executive order
Making sense of VBs acquisition of Stryker Spine.
VB website – https://www.vbllc.com I am going to share thoughts on this interesting acquisition. I don’t have any inside information
How to use a Virtual Assistant
Discover how to choose and use a Virtual Assistant to boost productivity with expert tips on task delegation and management.
UPDATE – The FTC’s non-compete ban moves down to the individual states.
UPDATE – The FTC proposed to ban noncompete agreements. The ban would have applied to for-profit entities but not to